Rcadia Closes $3.3 Million Investment Led by BioVentures
December 16, 2008 - Rcadia Medical Imaging Ltd., developer of the COR Analyzer software for the automated analysis of coronary CT angiography (CCTA) studies, closed a $3.3M investment round led by BioVentures Investors of Cambridge, MA.
The COR Analyzer is designed to enable rapid triage of chest pain patients. Immediately after a Coronary CTA study, the COR Analayzer identifies patients who need further evaluation for severe coronary artery disease, versus those who can be safely discharged. While improving emergency department (ED) workflow, the Rcadia application also can lead to more rapid diagnosis, enabling appropriate treatments and avoiding unnecessary delays for patients without coronary artery disease.
For more information: www.rcadia.com